News
IDIBELL assumes the functions of Biopol’H Consortium
The Bellvitge Biomedical Research Institute (IDIBELL) has integrated the functions hitherto had the Biopol’H Consortium, as a catalyst for innovation projects in the environment of the Bellvitge University Hospital, the Catalan Institute of Oncology at L’Hospitalet de Llobregat and the Bellvitge Campus of the University of Barcelona. Biopol’H Consortium was formally broken up on December […]
The Mediterranean diet reduces the risk of breast cancer
A high adherence to the Mediterranean diet reduces the risk of breast cancer by 6% in women in general, and by 7% in post-menopausal women. The study, published in the International Journal of Cancer, was attended by 335,062 women between 35 and 70 years. It is the largest epidemiological study carried out in the world […]
Developed new method to diagnose hereditary breast and ovarian cancer
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective. […]
“Ho portes a la sang” and “7 Minutos”, winners at BiomediCine, the first biomedicine video contest
The BiomediCine Award ceremony take place on January 16th in UB Bellvitge Campus. Biomedicine was organized by Biopol’H, UB and the University Hospital of Bellvitge On January 16th took place the award ceremony of BiomediCine, the biomedical video competition organized by Biopol’H, the UB and the University Hospital of Bellvitge. The winning videos will be […]
Manel Esteller appointed as Associate Editor of The Journal of the National Cancer Institute
Manel Esteller, Director of the Cancer Epigenetics and Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research Professor and Genetics Professor of the University of Barcelona has been appointed Associate Editor of The Journal of the National Cancer Institute (JNCI). The journal publishes peer-reviewed original research from around the world and is internationally […]
Manolis Kogevinas: ”Circadian rhythm disruption increases cancer risk”
The circadian rhythm is related with various diseases, including some cancers such as breast and prostate cancers. Manolis Kogevinas, researcher at the Centre for Research in Environmental Epidemiology (CREAL), warned of the risks to health of altering the biological rhythm, during an IDIBELL seminar held in the conference hall Pau Viladiu, at the Duran I […]
Good oral health reduces the risk of muscle injury
Maintaining a proper oral health is essential to prevent or minimize the risk of muscle injury in elite athletes. This is the main conclusion of the study leaded by Dr. Cosme Gay Escoda, researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and the medical team of FC Barcelona. For three seasons, from 2003 to 2006, […]
Researchers describe a key mechanism in muscle regeneration
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have described a new selectively target in muscle regeneration. This is the association of alpha-enolase protein and plasmin. The finding could be used to develop new treatments to regenerate muscular injuries or dystrophies. The study was published in the PLOS ONE journal. Skeletal muscle has a great […]
Janet Treasure: ”The eating disorder becomes the only friend of the patients”
The eating behavior disorders are complex problems that involve genetic, environmental and family. The Director of the Eating Disorders Service at South London & Maudsley NHS Foundation Trust and Professor of Psychiatry at Guy’s, King’s & St Thomas’ School of Medicine, London, Janet Treasure, gave a lecture on these ever more prevalent diseases in the […]